Abbreviation/Shorthand,Meaning,More Info
m-VEINES-QOL/Sym,modified Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Symptoms,
M/H,medical history,
M/R/G,"murmurs, rubs, gallops",
M0,Cancer has not metastacized,https://www.cancer.gov/about-cancer/diagnosis-staging/staging
M1,Cancer has metastacized,https://www.cancer.gov/about-cancer/diagnosis-staging/staging
M1,"sphenoidal segment (stem), middle cerebral artery",
M2,"insular segment, middle cerebral artery",
M3,"opercular segments, middle cerebral artery",
M4,"terminal or cortical segments, middle cerebral artery",
MA,metabolic acidosis,
MA,maxillary artery,
MA,migraine with aura,
MAA,Mycotic Aortic Aneurysm,
mAbs,monoclonal antibodies,
MAC,monitored anesthesia care,
MAC,Mycobacterium avium complex,
MAC-ELISA,monoclonal antibody capture enzyme-linked immunosorbent assay,
MACE,major adverse cardiac event,
MACI,matrix autologous chondrocyte implant ,
MACS,Manual Ability Classification System,
MADRS,Montgomery–Åsberg Depression Rating Scale,
MAF,mitral annular flutter,
MAG,myelin-associated glycoprotein,
MAI,Mycobacterium avium-intracellulare infection,
MALT,mucosa-associated lymphoid tissue,
MAMC,mid-arm muscle circumference,
mane,in the morning,
MAO,monoamine oxidase,
MAO-B,monoamine oxidase B,
MAOI,monoamine oxidase inhibitor,https://www.ncbi.nlm.nih.gov/books/NBK539848/
MAP,mean arterial pressure,
MAPHR,maximum age-predicted heart rate,
MAPK,mitogen-activated protein kinase,
MAPS,medical advanced pain specialist,
MAR,melanoma-associated retinopathy,
MARS,Methionyl-TRNA Synthetase 1,
MARS,molecular absorbents recirculation system,
MAS,modified Ashworth scale,
MASCC,Multinational Association for Supportive Care,
MAT,medication-assisted treatment,
MB,microbleed,
Mb,myoglobin,
MBB,medial branch block,
MBC,metastatic breast cancer,
MC,microscopic colitis,
MC,Modic change,
MCA,motorcycle accident,
MCA,middle cerebral artery,
MCB,monochlorobimane,
MCC,Merkel cell carcinoma,
MCFC,middle cheek fat compartment,
mcg,microgram,
MCH,mean corpuscular hemoglobin,
MCHC,mean corpuscular hemoglobin concentration,
MCII,minimum clinically important improvement,
MCL,mucinous cystic lesion,
MCL,medial collateral ligament,
MCM,major congenital malformation,
MCN,mucinous cystic neoplasm,
mCNV,myopic choroidal neovascularization,
MCOT,mobile cardiac outpatient telemetry,
mCRC,metastatic colorectal cancer,
mCRPC,metastatic castration-resistant prostate cancer,
MCT,medium‐chain triglyceride,
MCTD,mixed connective tissue disease,
MCTD,Mixed Connective Tissue Disease,
MCV,mean corpuscular volume,
MD,muscular dystrophy,
MDD,major depressive disorder,
MDD,minimally detectable difference,
MDE,minimum detectable effect,
MDF,Maddrey discriminant function,
MDI,metered dose inhaler,
MDMA,"3,4-methylenedioxy-methamphetamine",
MDR,multidrug-resistant,
MDS,myelodysplastic syndrome,
MECC,Minimal Extracorporeal Circulation,
MED,morphine equivalent dosage,
MEK,mitogen-activated protein kinase kinase,https://en.wikipedia.org/wiki/Mitogen-activated_protein_kinase_kinase
MELAS,"mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes",
MELD,Model for End Stage Liver Disease,
MELS,modular extracorporeal liver support system,
MENS,MICROCURRENT ELECTRICAL NERVE STIMULATION,
MEP,motor evoked potential,
MEP,magnetic evoked potential,
mEq,milliequivalent,
mEq/L,milliequivalents per liter,
MERRF,myoclonic epilepsy with ragged red fibers,
MERS,Middle East Respiratory Syndrome,
MERS-CoV,Middle East Respiratory Syndrome Coronavirus,
MeSH,medical subject heading,
MET,"MET proto-oncogene, receptor tyrosine kinase",https://www.mycancergenome.org/content/gene/met/
MET,Metabolic Equivalent,
MET,motivational enhancement therapy,
METS,Measurement of Exercise Tolerance before Surgery,
MF,malar fat,
MF,mandibular fossa,
MF,myelofibrosis,
MFC,medial femoral condyle,
MFCL,Medicare Functional Classification Level,
MFO,multi field optimization,
MFO-IMPT,multifield optimization intensity-modulated proton therapy,
MFO-IMRT,multifield optimization intensity-modulated radiation therapy,
MFS,metastasis-free survival,
Mg,magnesium,
mg,milligram,
MG,myasthenia gravis,
mg/dL,milligrams per deciliter,
MGMT,O[6]-methylguanine-DNA methyltransferase,
MgSO4,Magnesium Sulfate,
MgSO₄,Magnesium sulfate,
MHA,Minnesota Handwriting Assessment,
MHC,major histocompatibility complex,
MHD,mean heart dose,
MHD,maintenance hemodialysis,
MHOP,mental health outpatient services,
MHP,moist hot pack,
MHV,mouse hepatitis virus,
MHV,Murine Hepatitis Virus,
MHz,megahertz,
MI,myocardial infarction,
MI,molecular intelligence,
MIC,minimum inhibitory concentration,
MID,minimal important difference,
mIDH1,mutant isocitrate dehydrogenase 1,
midi,midday,
MILD,minimally invasive lumbar decompression,
MIONM,multimodal intraoperative neurophysiological monitoring,
MIP,maximal inspiratory pressure,
MIP,molecular inversion probe,
MIrAVR,minimally invasive reoperative aortic valve replacement,
MIRCT,massive irreparable rotator cuff tear,
MIS-A,multisystem inflammatory syndrome in adults,
MIS-C,multisystem inflammatory syndrome in children,
ML,Microlaryngoscopy,
mLAP,mean left atrial pressure,
MLD,manual lymphatic drainage,
MLTC,managed long term care,
MM,multiple myeloma,
MMA,multimodal analgesic,
MMA,maxillomandibular advancement ,
MMC,Mitomycin C,
MME,Morphine Milligram Equivalents,
MMF,maxillomandibular fixation,
mmHg,millimeter of mercury,
MMLV,Moloney murine leukemia virus,
MMLV-RT,Moloney murine leukemia virus reverse transcriptase,
MMMP,multimodal mental practice,
MMN,multi-focal motor neuropathy,
mmol,millimole,
mmol/L,millimole per liter,
MMSE,mini-mental state examination,
MMT,manual muscle testing,
MMTP,Methadone Maintenance Treatment Program,
MN,midnight,
MO,migraine without aura,
MO,morbid obesity,
MOA,mechanism of action,
MOCA,mechanochemical ablation,
MODQ,Modified Oswestry Disability Questionnaire,
MOG,myelin oligodendrocyte glycoprotein,
MOH,medication overuse headache,
MOI,multiplicity of infection,
MOLST,medical orders for life-sustaining treatment,
MOM,milk of magnesia,
MOSF,multiple organ system failure,
MP,methylprednisolone,
MP,mental practice,
MP,molecular profiling,
MP,mastoid process,
MP-NAAT,multiplex nucleic acid amplification test,
mPCR,multiplex polymerase chain reaction,
MPD,myofascial pain-dysfunction,
MPEC,memory precursor effector cell,
MPFL,medial patellofemoral ligament,
MPH,methylphenidate,
MPI,myocardial perfusion imaging,
MPJ,Metatarsal Phalangeal Joint,
MPK,microprocessor-controlled prosthetic knee,
MPL,Medial Patella Luxation,
MPLS,multiport laparoscopic surgery,
MPN,myeloproliferative neoplasm,
MPNST,malignant peripheral nerve sheath tumor,
Mpro,main protease,
MR,magnetic resonance,
MR,mental retardation,
MR,mitral regurgitation,
MR-proADM,mid-regional pro-adrenomedullin,
MR-SWI,magnetic resonance-susceptibility weighted imaging,
MRA,magnetic resonance angiography,
MRA,mandibular repositioning appliance,
MRADL,mobility-related activity of daily living,
MRC,mitochondrial respiratory chain,
MRCP,Magnetic Resonance Cholangiopancreatogram,
MRCP,mental retardation with cerebral palsy,
MRD,minimal residual disease,https://www.mdanderson.org/cancerwise/what-is-minimal-residual-disease--mrd--multiple-myeloma-lymphoma-leukemia-patients.h00-159383523.html
MRD,margin to reflex distance,
MRE,magnetic resonance elastography ,
MRF,multiple risk factors,
MRgFUS,Magnetic Resonance Guided Focused Ultrasound,
MRI,magnetic resonance imaging,
MRM,Modified Radical Mastectomy,
mRNA,messenger RNA,
MRSA,methicillin-resistant Staphylococcus aureus,
MRV,magnetic resonance venogram,
MS,mental status,
MS,mitral stenosis,
MS,morphine sulphate,
MS,multiple sclerosis,
MS,musculoskeletal,
MSA,magnetic sphincter augmentation,
MSA,multiple system atrophy,
MSAFP,Maternal Serum Alpha-Fetoprotein,
MSC,melanoma skin cancer,
MSC,mesenchymal stem cell,
msec,millisecond,
MSI,microsatellite instability,
MSIS,multi-system inflammatory syndrome,
MSK-IMPACT,Memorial Sloan-Kettering integrated mutation profiling of actionable cancer targets,
MSKCC,Memorial Sloan-Kettering Cancer Center,
MSLT,Multiple Sleep Latency Test,
MSSA,methicillin-sensitive Staphylococcus aureus,
MSU,monosodium urate,
MT,mechanical thrombectomy,
MTB,Maximum Therapeutic Benefit,
mtDNA,mitochondrial DNA,
MTF,male-to-female,
MTHFR,methylenetetrahydrofolate reductase,
mTOR,mammalian target of rapamycin,
MTP,metatarsophalangeal,
MTX,methotrexate,
MUA,manipulation under anesthesia,
mUI,milli-international units,
Multi-D,multi-disciplinary,
MuSK,Muscle-Specific Kinase,
MV,mechanical ventilation,
MVA,motor vehicle accident,
MVC,maximal voluntary contraction,
MVD,multi-vessel disease,
MVIC,maximum volitional isometric contraction,
MVO,microvascular obstruction,
MVP,mitral valve prolapse,
MVR,Mitral Valve Replacement,
MVS,mitral valve surgery,
MVV,Mitral Valve Valvuloplasty,
MWS,Mowat-Wilson syndrome,
MX,metastasis cannot be measured,
MX,Distant metastasis cannot be measured,https://www.cancer.gov/about-cancer/diagnosis-staging/staging
MZ,heterozygous Z allele,
μg,microgram,